H ysterosalpingo-contrast sonography (HyCoSy) is a technique that allows the sonographic assessment of tubal patency and examination of the uterine cavity after administration of a saline solution or contrast medium inserted through the cervix. The assessment of tubal permeability is part of a basic infertility study. Fallopian tube patency has classically been evaluated by hysterosalpingography (HSG). This diagnostic technique has 2 main problems: the radiology service should be involved, and both ionizing radiation and an iodinated contrast medium are needed. Thus, an infertility diagnosis can be somewhat delayed, and agents that are hypothetically deleterious to germ cells are used.
Hysterosalpingo-contrast sonography was first described in 1984 1 as the use of hypertonic contrast and abdominal sonography to assess the permeability of at least one tube, but it was not until 1986 when the first HyCoSy model was developed. 2 This technique was developed in an attempt to offer a more-accessible and safer diagnostic tool for gynecologists who aimed to study fallopian tube patency. Currently endorsed and recommended by numerous scientific societies throughout the world (such as Sociedad Española de Ginecolog ıa y Obstetricia, Sociedad Espaola de Fertilidad, and European Society of Human Reproduction and Embryology), 3 in our country, HyCoSy remains a scarcely implemented technique.
Many studies in recent years have indicated that HyCoSy is a good diagnostic technique, with sensitivity and specificity similar to those of traditional HSG and laparoscopic chromopertubation (reference standard) for the assessment of tubal patency. In the 1990s, several meta-analyses 4 and review studies 5 reported high concordance for tubal patency between HyCoSy and HSG or laparoscopy. Similar results were obtained in prospective series by Deichert et al 6 and Strandell et al. 7 Recently, Yu et al, 8 in a meta-analysis that included evaluations of 1037 tubes, and Alc azar et al, 9 in another meta-analysis in which 970 tubes were studied, concluded that HyCoSy was an accurate test for diagnosis of tubal patency in infertile women. Several smaller studies, both prospective and retrospective, from various countries were consistent with those studies. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Thus, HyCoSy is an effective method for evaluation of tubal patency, which is an essential part of a fertility workup.
On the other hand, what is the state of the evidence about assessment of the uterine cavity by HyCoSy? Regarding the evaluation of endometrial disease, in 2011, Luciano et al 23 compared endometrial findings after performing HyCoSy and hysteroscopy. They conducted a prospective study of 58 patients, which found 100% concordance between HyCoSy and hysteroscopy. The main difference between that study and ours was that they used a saline solution to enhance the virtual uterine cavity, whereas we used a sulfur hexafluoride contrast agent, which enables better visualization of the inner fallopian tubes. The accuracy of saline contrast for evaluation of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding was also recently assessed in a metaanalysis. 24 Nevertheless, sonographic evaluations of endometrial disease have not been clearly assessed to date. Thus, the purpose of our study was to assess the accuracy of HyCoSy for evaluation of intrauterine cavitary disease. Our hypothesis was that HyCoSy is a technique for evaluation of tubal patency that could replace the classic HSG in the future. It can show endocavitary anomalies in a very accurate way and seems to be more efficient and better tolerated than HSG. Secondary objectives included analyses of pain perceived by the patients, the rate of tubal patency, the amount of contrast material used, and the rate of complications.
Materials and Methods
This prospective observational study was approved by our institutional Ethics Committee (Puerta de Hierro Hospital Comit es de Etica en Investigaci on Cl ınica). Informed consent was obtained from patients who underwent HyCoSy in our center, informing them of the need to perform hysteroscopy in cases with suspicion of endometrial anomalies. Hysterosalpingo-contrast sonography and hysteroscopy were performed by different providers, but the operator who performed the hysteroscopy already knew the results of HyCoSy and was present during the sonographic examination in most of the pathologic cases. Inclusion criteria were as follows: patients undergoing infertility studies, informed consent read and signed, partner with normal or minor abnormal findings on spermiography that could allow the performance of intrauterine inseminations, and HyCoSy findings of endocavitary anomalies. Exclusion criteria were known allergies to the contrast medium, known tubal obstruction, active pelvic infection, and unfocused fever. Patients with intrauterine endocavitary pathologic findings were referred for hysteroscopy, which was done a few days after HyCoSy.
Hysterosalpingo-Contrast Sonographic Technique
Patients should be in the follicular phase of the menstrual cycle. Except in cases of known allergies to any of the compounds, the premedication prescribed at the previous office (1 g of oral azithromycin the night before the test and 600 mg of oral ibuprofen 1 hour before the procedure) was administrated.
A speculum, 20-mL syringe, ring clamp, saline solution, and pediatric nasogastric tube were used for the examination. The contrast medium used was a commercially available hyperechoic sulfur hexafluoride agent (SonoVue; Bracco SpA, Milan, Italy). In a sterile canister, 1 mL of the contrast medium was mixed with 20 mL of a saline solution, and the mixture was shaken gently before use. Patients with suspected endometrial anomalies on HyCoSy were then referred to the hysteroscopy office.
Hysteroscopic Technique
Hysteroscopy is performed in the first phase of the menstrual cycle. Informed consent was obtained and premedication given to patients 1 hour before the procedure (600 mg of ibuprofen, 5 mg of diazepam, and buscapine). The equipment necessary to perform the test included a hysteroscopy tower with a 300-W xenon light source, a camera, an infusion pump, and television monitor, and an image capture and digital recording system. A continuous-flow Bettocchi diagnostic hysteroscope (Karl Storz, Tuttlingen, Germany) with a 7F working channel was used, with saline serum as a means of distension and 30 8 optics. Accessory equipment included mechanical instruments (directed biopsy forceps, forceps or grippers, and scissors) and a Versapoint bipolar electrosurgical system (Ethicon, Summerville, NJ).
Entry was made by a vaginoscopic technique, and the ectocervix was identified by visualizing all of its contour. Next, the characteristics of the endocervix and possible anomalies at that level were evaluated, as well as the possibilities of resolving them during the same procedure. Once the internal cervical orifice was crossed, the uterine cavity was evaluated. After an overview of the cavity, both regions and the tubal ostia were visualized by rotating the optic on its axis. Next, the appearance of the endometrium was evaluated; if there were endocavitary anomalies, treatment was performed during same procedure ("see-and-treat" approach).
Statistical Analysis
A descriptive analysis was conducted by calculating means and standard deviations or medians and 25th and 75th percentiles when a normality assumption was not accomplished for numerical variables and absolute and relative frequencies for categorical variables. A graphic descriptive analysis was also performed using histograms, bar graphs, and sectors. The concordance between 
Descriptive Numerical Variables
The median age of our patients was 34 years. The median contrast agent dose used was 20 mL. The median number of antral follicles was 7, both for the right and left ovaries. The median pain score (according to an analog pain scale of 1-10) 25 was 2 of 10 (minimum, 1; maximum, 7).
Descriptive Categorical Variables
All of the scans were performed with SonoVue (90 of 90 [100%]). In terms of internal cervical orifice channeling, 88% of the patients were channeled with a pediatric nasogastric tube only; 9% needed channeling with a rigid cannula and guarantor; and only 3% needed cervical canalization with a rigid cannula and Pozzi clamp.
Sixty-seven of the 90 patients (74.4%) had permeability of the right fallopian tube; 20 of 90 (22%) had negative permeability; and in 3 of 90 (3.3%), tubal patency could not be evaluated. On the left side, the contrast media passed through the fallopian tube in 70 of 90 patients (77.7%); 19 of 90 (21%) had negative permeability; and only in 1 of 90 (1%), tubal patency could not be evaluated. None of our patients presented had.
In All of the sonographic findings were confirmed by hysteroscopy. There was excellent agreement between both tests. The expected agreement was 77.88%, which was widely exceeded in our patients by remarkable observed agreement of 100% (Table 1 ). The patients evaluated in our study also had very low median pain intensity during the test, according to the analog pain scale. Finally, of the 90 studied patients, nonendometrial gynecologic anomalies were noticed in 75 of 90 cases (83.3%): 6 of 90 patients (6.6%) had ovarian cysts, and 4 of 90 (4.4%) had nonsubmucosal leiomyomas.
Discussion
The concordance between the contrast-enhanced features of endometrial anomalies evaluated by HyCoSy and hysteroscopic findings from the patients in this study was 100%, as the 15 cavitary anomalies found on HyCoSy were confirmed by hysteroscopy. The main limitation of our study is that we cannot assume that HyCoSy is an accurate technique for evaluation of the uterine cavity overall, as we did not perform hysteroscopy in normal cavities. Our patients also had very low pain intensity during the test, and no complications occurred in any of the 90 patients undergoing the test.
Hysterosalpingo-contrast sonography also seems to have other advantages compared to HSG. First, it can be performed by gynecologists in their offices; the procedure can be done quickly; and the results should be obtained more quickly than with traditional HSG, in which the patient should be referred to a radiologist and would be exposed to a more expensive examination that involves ionizing radiation. Moreover, a transvaginal sonographic examination allows an evaluation of uterine and ovarian morphologic characteristics in the same unique step, making it possible to evaluate the ovarian reserve and associated gynecologic anomalies such as leiomyomas and ovarian cysts. Finally, HyCoSy seems to be less painful for patients and is accompanied by fewer vagal reactions. 27 It also avoids exposure to ionizing radiation. Intrauterine instillation of the contrast material gives important information about the cervical catheterization, which could hypothetically help in future intrauterine insemination.
Thus, based on a review of the literature, HyCoSy appears to be the most comprehensive study while maintaining competitive diagnostic accuracy for tubal patency. The principal limitation of this study is that we do not have evidence that normal cavities on HyCoSy were in fact normal, since none of those patients underwent hysteroscopy to confirm the HyCoSy findings; therefore, this work was a pilot study, and our results and conclusions need to be interpreted as such. A future study should be performed in which all patients undergo both tests to determine the true accuracy of HyCoSy as a tool for evaluating the uterine cavity.
In conclusion, HyCoSy is a very well-tolerated test with a very low rate of complications. In addition to the advantages published in the literature on HyCoSy compared to classic HSG, such as the avoidance of ionizing radiation, less pain perceived by the patient, and the possibility of having gynecologists do the examination in the office (shorter waiting time), it enables a simultaneous evaluation of the ovarian reserve and structure, uterine cavity contour and myometrial structure, and tubal architecture and patency.
